Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118485313 | 11848531 | 3 | F | 2013 | 20160824 | 20151218 | 20160901 | EXP | US-PFIZER INC-2015396524 | PFIZER | 66.00 | YR | F | Y | 115.00000 | KG | 20160901 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118485313 | 11848531 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | 18989 | TABLET | |||||||||
| 118485313 | 11848531 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | 18989 | TABLET | |||||||||||
| 118485313 | 11848531 | 3 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | 4-5 200MG TABLETS AN AVERAGE OF 2-3 TIMES A WEEK | Y | 18989 | TABLET | ||||||||
| 118485313 | 11848531 | 4 | SS | IBUPROFEN. | IBUPROFEN | 1 | Y | 18989 | TABLET | ||||||||||
| 118485313 | 11848531 | 5 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | ||||||||
| 118485313 | 11848531 | 6 | C | SENOKOT | SENNOSIDES | 1 | UNK | 0 | |||||||||||
| 118485313 | 11848531 | 7 | C | BUPROPION. | BUPROPION | 1 | UNK | 0 | |||||||||||
| 118485313 | 11848531 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | 0 | |||||||||||
| 118485313 | 11848531 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 118485313 | 11848531 | 10 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | 0 | |||||||||||
| 118485313 | 11848531 | 11 | C | Regular insulin | INSULIN NOS | 1 | UNK | 0 | |||||||||||
| 118485313 | 11848531 | 12 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | UNK | 0 | |||||||||||
| 118485313 | 11848531 | 13 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 118485313 | 11848531 | 14 | C | ALEVE | NAPROXEN SODIUM | 1 | UNK | 0 | |||||||||||
| 118485313 | 11848531 | 15 | C | MULTIVITAMINS | VITAMINS | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118485313 | 11848531 | 1 | Osteoarthritis |
| 118485313 | 11848531 | 2 | Rheumatoid arthritis |
| 118485313 | 11848531 | 3 | Headache |
| 118485313 | 11848531 | 4 | Osteoarthritis |
| 118485313 | 11848531 | 5 | Prophylaxis |
| 118485313 | 11848531 | 6 | Supplementation therapy |
| 118485313 | 11848531 | 7 | Depression |
| 118485313 | 11848531 | 8 | Hypothyroidism |
| 118485313 | 11848531 | 9 | Diabetic neuropathy |
| 118485313 | 11848531 | 10 | Type 2 diabetes mellitus |
| 118485313 | 11848531 | 11 | Type 2 diabetes mellitus |
| 118485313 | 11848531 | 12 | Osteoarthritis |
| 118485313 | 11848531 | 13 | Depression |
| 118485313 | 11848531 | 14 | Osteoarthritis |
| 118485313 | 11848531 | 15 | Supplementation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118485313 | 11848531 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118485313 | 11848531 | Chronic kidney disease | |
| 118485313 | 11848531 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118485313 | 11848531 | 1 | 20120922 | 20121011 | 0 | |
| 118485313 | 11848531 | 3 | 1985 | 2014 | 0 | |
| 118485313 | 11848531 | 5 | 20120922 | 20121019 | 0 |